Your browser is no longer supported. Please, upgrade your browser.
Settings
INFI Infinity Pharmaceuticals, Inc. daily Stock Chart
INFI [NASD]
Infinity Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.77 Insider Own3.00% Shs Outstand57.06M Perf Week-6.40%
Market Cap66.76M Forward P/E- EPS next Y-0.82 Insider Trans0.00% Shs Float54.97M Perf Month1.74%
Income-43.90M PEG- EPS next Q-0.19 Inst Own52.80% Short Float0.13% Perf Quarter1.74%
Sales2.90M P/S23.02 EPS this Y-131.50% Inst Trans0.00% Short Ratio0.58 Perf Half Y-27.33%
Book/sh0.33 P/B3.55 EPS next Y0.00% ROA-66.90% Target Price3.13 Perf Year-8.59%
Cash/sh0.91 P/C1.28 EPS next 5Y- ROE-125.40% 52W Range0.82 - 1.95 Perf YTD21.87%
Dividend- P/FCF- EPS past 5Y40.20% ROI-22.70% 52W High-40.00% Beta1.86
Dividend %- Quick Ratio6.20 Sales past 5Y- Gross Margin- 52W Low42.68% ATR0.07
Employees25 Current Ratio6.20 Sales Q/Q-98.60% Oper. Margin- RSI (14)55.63 Volatility5.37% 7.00%
OptionableYes Debt/Eq0.00 EPS Q/Q-186.20% Profit Margin- Rel Volume1.39 Prev Close1.19
ShortableYes LT Debt/Eq0.00 EarningsJan 29 AMC Payout- Avg Volume120.12K Price1.17
Recom2.40 SMA205.36% SMA504.77% SMA200-12.65% Volume166,968 Change-1.68%
Jun-27-19Initiated Oppenheimer Outperform
Jan-04-19Initiated B. Riley FBR Buy $3
Nov-12-18Downgrade Wells Fargo Outperform → Market Perform
Nov-12-18Downgrade JP Morgan Neutral → Underweight
Oct-12-17Upgrade Wells Fargo Market Perform → Outperform
Aug-10-16Reiterated Wedbush Neutral $1.25 → $1
Jun-15-16Downgrade Wells Fargo Outperform → Market Perform
Jun-15-16Downgrade RBC Capital Mkts Outperform → Sector Perform $12 → $2
Jun-15-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-15-16Downgrade Jefferies Buy → Hold
Jun-14-16Downgrade JP Morgan Overweight → Neutral
Jun-14-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-14-16Downgrade FBR Capital Outperform → Mkt Perform $15 → $2
Mar-02-16Initiated FBR Capital Outperform $15
Feb-25-16Reiterated Wedbush Neutral $9 → $8
Sep-21-15Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-07-15Reiterated RBC Capital Mkts Outperform $18 → $15
May-07-15Initiated Deutsche Bank Buy $20
Oct-20-14Resumed Stifel Hold
Mar-06-13Reiterated Stifel Buy $39 → $50
Jan-13-20 07:35AM  Infinity Pharmaceuticals Provides 2020 Goals and Financial Guidance Business Wire -5.60%
Jan-09-20 09:00AM  Verastem In-Licenses KRAS-Focused Drug From Chugai, Stock Up Zacks +11.21%
07:35AM  Infinity Pharmaceuticals Raises $20 Million Through an Innovative Non-Dilutive Asset-Backed Financing from BVF Business Wire
07:05AM  Infinity Pharmaceuticals to Present Corporate Overview at 38th Annual J.P. Morgan Global Healthcare Conference Business Wire
Dec-20-19 06:23PM  Infinity Pharmaceuticals Inc. (INFI): Are Hedge Funds Right About This Stock? Insider Monkey
Nov-09-19 10:24PM  Edited Transcript of INFI earnings conference call or presentation 30-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Oct-31-19 12:45PM  Infinity (INFI) Q3 Loss Wider Than Expected, IPI-549 in Focus Zacks
Oct-30-19 06:25PM  Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:03PM  Infinity Pharmaceuticals Provides Company Update and Third Quarter 2019 Financial Results Business Wire
Oct-23-19 08:33AM  Infinity Announces the Date of Its Third Quarter 2019 Financial Results Conference Call and Webcast Business Wire
Oct-08-19 10:02AM  Verastem's (VSTM) Copiktra Gets Orphan Drug Designation Zacks
09:18AM  Infinity's (INFI) IPI-549 in Focus in a Crowded Cancer Space Zacks
Sep-05-19 10:24AM  Infinity Initiates 2 Studies for Lead Candidate IPI-549 Zacks
Sep-04-19 08:32AM  Infinity Pharmaceuticals Announces the Initiation of Two Clinical Trials Evaluating IPI-549 in Novel Triple Combination Therapies for the Treatment of Solid Tumors PR Newswire
Sep-03-19 08:32AM  Infinity to Present at Two Upcoming Conferences in September PR Newswire
Aug-29-19 09:31AM  Infinity (INFI) Down 22.5% Since Last Earnings Report: Can It Rebound? Zacks
Aug-22-19 04:03PM  Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of Directors PR Newswire
Aug-03-19 07:50AM  Edited Transcript of INFI earnings conference call or presentation 30-Jul-19 12:00pm GMT Thomson Reuters StreetEvents
Jul-31-19 10:16AM  Infinity (INFI) Q2 Loss Wider Than Expected, Sales Miss Zacks -6.37%
Jul-30-19 08:55AM  Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Lags Revenue Estimates Zacks
07:32AM  Infinity Pharmaceuticals Provides Company Update and Second Quarter 2019 Financial Results PR Newswire
Jul-23-19 08:32AM  Infinity Announces The Date Of Its Second Quarter 2019 Financial Results Conference Call And Webcast PR Newswire -5.99%
Jun-24-19 08:33AM  Verastem Up on Positive Data From Early-Stage Copiktra Study Zacks
Jun-06-19 09:31AM  Infinity (INFI) Up 6% Since Last Earnings Report: Can It Continue? Zacks
May-29-19 08:32AM  Infinity Pharmaceuticals To Present At The 2019 BIO International Convention PR Newswire
May-16-19 08:32AM  Infinity Pharmaceuticals To Present At B. Riley FBR Institutional Investor Conference PR Newswire
May-15-19 12:54AM  Edited Transcript of INFI earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 09:33AM  Infinity (INFI) Earnings and Sales Miss Estimates in Q1 Zacks -11.76%
May-07-19 07:25PM  Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Lags Revenue Estimates Zacks
06:14PM  Infinity: 1Q Earnings Snapshot Associated Press
04:05PM  Infinity Pharmaceuticals Provides Company Update and First Quarter 2019 Financial Results PR Newswire
Apr-30-19 08:32AM  Infinity Announces the Date of Its First Quarter 2019 Financial Results Conference Call and Webcast PR Newswire
Apr-13-19 09:30AM  Infinity (INFI) Down 10% Since Last Earnings Report: Can It Rebound? Zacks
Apr-10-19 11:10AM  Beat Q1 Earnings Woes With These Sector ETFs & Stocks Zacks
Apr-02-19 08:32AM  Infinity Pharmaceuticals To Present At The 18th Annual Needham Healthcare Conference PR Newswire -5.35%
Mar-28-19 08:21AM  Will Infinity Pharmaceuticals Continue to Surge Higher? Zacks
Mar-25-19 09:00AM  Infinity (INFI) Upgraded to Buy: Here's What You Should Know Zacks
Mar-22-19 10:10PM  Edited Transcript of INFI earnings conference call or presentation 14-Mar-19 12:00pm GMT Thomson Reuters StreetEvents
Mar-18-19 11:26AM  Karyopharm Stock Up Even as FDA Delays Selinexor NDA Verdict Zacks
09:22AM  Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-15-19 11:37AM  Infinity Inks Deal With Roche for Phase II Study of IPI-549 Zacks -5.76%
Mar-14-19 09:50AM  Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates Zacks +24.03%
08:52AM  Infinity: 4Q Earnings Snapshot Associated Press
07:32AM  Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update PR Newswire
07:02AM  Infinity To Initiate MARIO-3, A Phase 2 Multi-Arm Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer And Renal Cell Cancer PR Newswire
05:00AM  Infinity Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-19 04:05PM  Infinity Announces the Date of Its Full Year 2018 Financial Results Conference Call and Webcast PR Newswire -9.36%
Mar-06-19 07:32AM  Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA for $30 Million Gross Proceeds PR Newswire
Feb-06-19 07:55AM  Analysis: Positioning to Benefit within Conagra Brands, National Retail Properties, PRA Health Sciences, Westinghouse Air Brake Technologies, YRC Worldwide, and Infinity Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-04-19 08:32AM  Infinity Pharmaceuticals To Present At BIO CEO & Investor Conference PR Newswire
Jan-07-19 07:32AM  Infinity Pharmaceuticals Provides 2019 Goals and Financial Guidance PR Newswire +8.87%
Jan-03-19 04:05PM  Infinity To Present At 37th Annual J.P. Morgan Healthcare Conference PR Newswire -5.60%
Dec-05-18 09:30AM  Infinity (INFI) Down 48.3% Since Last Earnings Report: Can It Rebound? Zacks
Nov-13-18 07:26AM  Edited Transcript of INFI earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
06:55AM  Todays Research Reports on Stocks to Watch: Infinity Pharmaceuticals and athenahealth ACCESSWIRE
Nov-10-18 06:02AM  Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting PR Newswire
Nov-09-18 08:35AM  Detailed Research: Economic Perspectives on MetLife, Callon Petroleum, Five9, Ballard Power, Infinity Pharmaceuticals, and Commercial Vehicle Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-07-18 10:50AM  Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer Zacks +6.41%
Nov-06-18 03:24PM  Infinity (INFI) Q3 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Nov-05-18 04:55PM  Infinity: 3Q Earnings Snapshot Associated Press
04:03PM  Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results PR Newswire
06:59AM  Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer PR Newswire
06:59AM  Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer Business Wire
Nov-01-18 02:23PM  Infinity Announces IPI-549 Late-Breaking Presentation at SITC 33rd Annual Meeting PR Newswire +17.50%
Oct-29-18 08:32AM  Infinity Announces the Date of Its Third Quarter 2018 Financial Results Conference Call and Webcast PR Newswire -5.09%
Oct-17-18 07:55AM  Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-11-18 08:32AM  Infinity To Present At BIO Investor Forum PR Newswire
Oct-03-18 08:40AM  Infinity Pharmaceuticals (INFI) Looks Good: Stock Adds 6.5% in Session Zacks
Oct-02-18 08:38AM  The Zacks Analyst Blog Highlights: Champions Oncology, CytoDyn, Infinity Pharmaceuticals, Nektar Therapeutics and Zoetis Zacks +6.51%
Oct-01-18 10:28AM  5 Best Biotech Stocks to Buy In October Zacks
08:32AM  Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA (duvelisib) And Updates 2018 Financial Guidance PR Newswire
Sep-27-18 05:11PM  /C O R R E C T I O N -- Infinity Pharmaceuticals, Inc./ PR Newswire
Sep-26-18 08:45AM  Options Traders Expect Huge Moves in Infinity (INFI) Stock Zacks
08:32AM  Infinity To Present At Cantor Fitzgerald Global Healthcare Conference PR Newswire
Sep-06-18 11:24AM  Infinity (INFI) Up 21.9% Since Last Earnings Report: Can It Continue? Zacks
Aug-28-18 08:32AM  Infinity To Present At Three Upcoming Investor Conferences In September PR Newswire
Aug-22-18 08:55AM  Infinity Focuses on Developing IPI-549 for Solid Tumors Zacks
08:00AM  Research Report Identifies America's Car-Mart, SAExploration, Ascena Retail Group, Infinity Pharmaceuticals, Hologic, and California Resources with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-17-18 01:40PM  Edited Transcript of INFI earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-18 09:27AM  Infinity (INFI) Posts Narrower-Than-Expected Loss in Q2 Zacks
Aug-07-18 05:26PM  Infinity: 2Q Earnings Snapshot Associated Press
04:05PM  Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results PR Newswire
02:30PM  Infinity Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
08:30AM  Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer PR Newswire
Aug-03-18 03:09PM  Why Boston and central Texas have so many of the best-paying companies in the U.S. Here's where other cities are missing out. American City Business Journals
Jul-31-18 04:05PM  Infinity Announces The Date Of Its Second Quarter 2018 Financial Results Conference Call And Webcast PR Newswire
Jul-13-18 07:30AM  Free Technical Research on Insmed and Three More Biotech Equities ACCESSWIRE
Jun-27-18 06:39PM  Infinity and Arcus Ink Deal for Two Triple Combo Studies Zacks
Jun-26-18 08:30AM  Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies PR Newswire
Jun-25-18 08:40AM  Is the Options Market Predicting a Spike in Infinity (INFI) Stock? Zacks
Jun-12-18 07:45AM  New Research: Key Drivers of Growth for CNA Financial, AutoNation, Hess, Infinity Pharmaceuticals, Regulus Therapeutics, and Weyerhaeuser Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire -5.41%
Jun-07-18 09:33AM  Infinity Pharmaceuticals (INFI) Down 6.7% Since Earnings Report: Can It Rebound? Zacks
Jun-04-18 07:30AM  Infinity Reports IPI-549 Clinical and Translational Data from Ongoing Phase 1/1b Study at American Society of Clinical Oncology Annual Meeting PR Newswire -7.96%
May-22-18 08:30AM  Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs Business Wire
May-11-18 09:36PM  Edited Transcript of INFI earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-09-18 02:12PM  Infinity (INFI) Incurs In-Line Loss in Q1, Maintains View Zacks
May-08-18 06:04PM  Infinity: 1Q Earnings Snapshot Associated Press -5.45%
04:07PM  Infinity Announces Presentations On IPI-549 At Upcoming American Society of Clinical Oncology Annual Meeting PR Newswire
04:05PM  Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results PR Newswire
May-03-18 11:39AM  Acorda (ACOR) Q1 Earnings Miss Estimates, Sales Down Y/Y Zacks
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for people with cancer in the United States. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma), which is in Phase 1/1b clinical study. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib, as well as duvelisib program, including DUO study that is in randomized and monotherapy Phase III clinical study for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol-Myers Squibb Company. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.